Rapamycin inhibits proteasome activator expression and proteasome activity

Xin Wang, Satoshi Omura, Luc I. Szweda, Young Yang, Jacques Bérard, Johnny Seminaro, Jiangping Wu

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Rapamycin (RAPA) is a potent immunosuppressive drug, and certain of its direct or indirect targets might be of vital importance to the regulation of an immune response. In this study, we used differential hybridization to search for human genes whose expression was sensitive to RAPA. Seven RAPA-sensitive genes were found and one of them coded a protein with high homology to the α subunit of a proteasome activator (PA28α). This gene was later found to code for the β subunit of the proteasome activator (PA28β). Activated T and B cells had up-regulated PA28β expression at the mRNA level. Such up-regulation could be suppressed by RAPA, FK506, and cyclosporin A. RAPA and FK506 also repressed the up-regulated PA28α messages in phytohemagglutinin (PHA)-stimulated T cells. At the protein level, RAPA inhibited PA28α and PA28β in the activated T cells according to immunoblotting and confocal microscopy. Probably as a consequence, there was a fourfold increase of proteasome activities in the peripheral blood mononuclear cell lysate after the PHA activation. PAPA could inhibit the enhanced part of the proteasome activity. Considering the critical role played by the proteasome in degrading regulatory proteins, our data suggest that the proteasome activator is a relevant and important downstream target of rapamycin, and that the immune response could be modulated through the activity of the proteasome.

Original languageEnglish (US)
Pages (from-to)2781-2786
Number of pages6
JournalEuropean Journal of Immunology
Volume27
Issue number11
DOIs
StatePublished - Nov 1 1997

Fingerprint

Proteasome Endopeptidase Complex
Sirolimus
Tacrolimus
Phytohemagglutinins
T-Lymphocytes
Proteins
Immunosuppressive Agents
Immunoblotting
Confocal Microscopy
Cyclosporine
Genes
Blood Cells
B-Lymphocytes
Up-Regulation
Gene Expression
Messenger RNA
Pharmaceutical Preparations

Keywords

  • Lactacystin
  • Lymphocyte activation
  • Proteasome
  • Proteasome activator
  • Rapamycin

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Rapamycin inhibits proteasome activator expression and proteasome activity. / Wang, Xin; Omura, Satoshi; Szweda, Luc I.; Yang, Young; Bérard, Jacques; Seminaro, Johnny; Wu, Jiangping.

In: European Journal of Immunology, Vol. 27, No. 11, 01.11.1997, p. 2781-2786.

Research output: Contribution to journalArticle

Wang, X, Omura, S, Szweda, LI, Yang, Y, Bérard, J, Seminaro, J & Wu, J 1997, 'Rapamycin inhibits proteasome activator expression and proteasome activity', European Journal of Immunology, vol. 27, no. 11, pp. 2781-2786. https://doi.org/10.1002/eji.1830271106
Wang, Xin ; Omura, Satoshi ; Szweda, Luc I. ; Yang, Young ; Bérard, Jacques ; Seminaro, Johnny ; Wu, Jiangping. / Rapamycin inhibits proteasome activator expression and proteasome activity. In: European Journal of Immunology. 1997 ; Vol. 27, No. 11. pp. 2781-2786.
@article{5b14c28eb92c40b79493f1665c774460,
title = "Rapamycin inhibits proteasome activator expression and proteasome activity",
abstract = "Rapamycin (RAPA) is a potent immunosuppressive drug, and certain of its direct or indirect targets might be of vital importance to the regulation of an immune response. In this study, we used differential hybridization to search for human genes whose expression was sensitive to RAPA. Seven RAPA-sensitive genes were found and one of them coded a protein with high homology to the α subunit of a proteasome activator (PA28α). This gene was later found to code for the β subunit of the proteasome activator (PA28β). Activated T and B cells had up-regulated PA28β expression at the mRNA level. Such up-regulation could be suppressed by RAPA, FK506, and cyclosporin A. RAPA and FK506 also repressed the up-regulated PA28α messages in phytohemagglutinin (PHA)-stimulated T cells. At the protein level, RAPA inhibited PA28α and PA28β in the activated T cells according to immunoblotting and confocal microscopy. Probably as a consequence, there was a fourfold increase of proteasome activities in the peripheral blood mononuclear cell lysate after the PHA activation. PAPA could inhibit the enhanced part of the proteasome activity. Considering the critical role played by the proteasome in degrading regulatory proteins, our data suggest that the proteasome activator is a relevant and important downstream target of rapamycin, and that the immune response could be modulated through the activity of the proteasome.",
keywords = "Lactacystin, Lymphocyte activation, Proteasome, Proteasome activator, Rapamycin",
author = "Xin Wang and Satoshi Omura and Szweda, {Luc I.} and Young Yang and Jacques B{\'e}rard and Johnny Seminaro and Jiangping Wu",
year = "1997",
month = "11",
day = "1",
doi = "10.1002/eji.1830271106",
language = "English (US)",
volume = "27",
pages = "2781--2786",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "11",

}

TY - JOUR

T1 - Rapamycin inhibits proteasome activator expression and proteasome activity

AU - Wang, Xin

AU - Omura, Satoshi

AU - Szweda, Luc I.

AU - Yang, Young

AU - Bérard, Jacques

AU - Seminaro, Johnny

AU - Wu, Jiangping

PY - 1997/11/1

Y1 - 1997/11/1

N2 - Rapamycin (RAPA) is a potent immunosuppressive drug, and certain of its direct or indirect targets might be of vital importance to the regulation of an immune response. In this study, we used differential hybridization to search for human genes whose expression was sensitive to RAPA. Seven RAPA-sensitive genes were found and one of them coded a protein with high homology to the α subunit of a proteasome activator (PA28α). This gene was later found to code for the β subunit of the proteasome activator (PA28β). Activated T and B cells had up-regulated PA28β expression at the mRNA level. Such up-regulation could be suppressed by RAPA, FK506, and cyclosporin A. RAPA and FK506 also repressed the up-regulated PA28α messages in phytohemagglutinin (PHA)-stimulated T cells. At the protein level, RAPA inhibited PA28α and PA28β in the activated T cells according to immunoblotting and confocal microscopy. Probably as a consequence, there was a fourfold increase of proteasome activities in the peripheral blood mononuclear cell lysate after the PHA activation. PAPA could inhibit the enhanced part of the proteasome activity. Considering the critical role played by the proteasome in degrading regulatory proteins, our data suggest that the proteasome activator is a relevant and important downstream target of rapamycin, and that the immune response could be modulated through the activity of the proteasome.

AB - Rapamycin (RAPA) is a potent immunosuppressive drug, and certain of its direct or indirect targets might be of vital importance to the regulation of an immune response. In this study, we used differential hybridization to search for human genes whose expression was sensitive to RAPA. Seven RAPA-sensitive genes were found and one of them coded a protein with high homology to the α subunit of a proteasome activator (PA28α). This gene was later found to code for the β subunit of the proteasome activator (PA28β). Activated T and B cells had up-regulated PA28β expression at the mRNA level. Such up-regulation could be suppressed by RAPA, FK506, and cyclosporin A. RAPA and FK506 also repressed the up-regulated PA28α messages in phytohemagglutinin (PHA)-stimulated T cells. At the protein level, RAPA inhibited PA28α and PA28β in the activated T cells according to immunoblotting and confocal microscopy. Probably as a consequence, there was a fourfold increase of proteasome activities in the peripheral blood mononuclear cell lysate after the PHA activation. PAPA could inhibit the enhanced part of the proteasome activity. Considering the critical role played by the proteasome in degrading regulatory proteins, our data suggest that the proteasome activator is a relevant and important downstream target of rapamycin, and that the immune response could be modulated through the activity of the proteasome.

KW - Lactacystin

KW - Lymphocyte activation

KW - Proteasome

KW - Proteasome activator

KW - Rapamycin

UR - http://www.scopus.com/inward/record.url?scp=0030715295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030715295&partnerID=8YFLogxK

U2 - 10.1002/eji.1830271106

DO - 10.1002/eji.1830271106

M3 - Article

C2 - 9394799

AN - SCOPUS:0030715295

VL - 27

SP - 2781

EP - 2786

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 11

ER -